Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with Nivolumab

Documenti analoghi

• Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system
  di: Ikeda, Mio, et al.
  Pubblicazione: (2020)
• Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients
  di: Yagi, Satomi, et al.
  Pubblicazione: (2017)
• Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients.
  di: Satomi Yagi, et al.
  Pubblicazione: (2017-01-01)
• Comparison of Systemic Inflammatory Response Syndrome and quick Sequential Organ Failure Assessment scores in predicting bacteremia in the emergency department
  di: Furuta, Katsuyuki, et al.
  Pubblicazione: (2021)
• CD24, not CD47, negatively impacts upon response to PD‐1/L1 inhibitors in non–small‐cell lung cancer with PD‐L1 tumor proportion score < 50
  di: Ozawa, Yuichi, et al.
  Pubblicazione: (2020)